National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

iodine I 131 tositumomab
A monoclonal antibody directed against the CD20 protein expressed on the surface of B-lymphocytes and radiolabeled with the radioisotope iodine I 131 with potential antineoplastic activity. Iodine I 131 tositumomab binds to and selectively delivers cyctotoxic radiation to CD20-expressing B-lymphocytes, thereby minimizing systemic radiotoxicity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:131-I-anti-B1 antibody
131-I-anti-B1 monoclonal antibody
iodine I 131 MOAB anti-B1
iodine I 131 monoclonal antibody anti-B1
iodine-131 anti-B1 antibody
iodine-131 anti-CD20 monoclonal antibody
Abbreviation:I131-MOAB-B1



Previous:iodine I 131 monoclonal antibody 3F8, iodine I 131 monoclonal antibody 81C6, iodine I 131 monoclonal antibody 8H9, iodine I 131 monoclonal antibody BC8, iodine I 131 monoclonal antibody CC49-deltaCH2
Next:iodine-123 metaiodobenzylguanidine, Iodotope, ipilimumab, ipomeanol, iproplatin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov